Literature DB >> 27898207

A Breathing-Based Meditation Intervention for Patients With Major Depressive Disorder Following Inadequate Response to Antidepressants: A Randomized Pilot Study.

Anup Sharma1,2, Marna S Barrett2, Andrew J Cucchiara3, Nalaka S Gooneratne4, Michael E Thase2.   

Abstract

OBJECTIVE: To evaluate feasibility, efficacy, and tolerability of Sudarshan Kriya yoga (SKY) as an adjunctive intervention in patients with major depressive disorder (MDD) with inadequate response to antidepressant treatment.
METHODS: Patients with MDD (defined by DSM-IV-TR) who were depressed despite ≥ 8 weeks of antidepressant treatment were randomized to SKY or a waitlist control (delayed yoga) arm for 8 weeks. The primary efficacy end point was change in 17-item Hamilton Depression Rating Scale (HDRS-17) total score from baseline to 2 months. The key secondary efficacy end points were change in Beck Depression Inventory (BDI) and Beck Anxiety Inventory (BAI) total scores. Analyses of the intent-to-treat (ITT) and completer sample were performed. The study was conducted at the University of Pennsylvania between October 2014 and December 2015.
RESULTS: In the ITT sample (n = 25), the SKY arm (n = 13) showed a greater improvement in HDRS-17 total score compared to waitlist control (n = 12) (-9.77 vs 0.50, P = .0032). SKY also showed greater reduction in BDI total score versus waitlist control (-17.23 vs -1.75, P = .0101). Mean changes in BAI total score from baseline were significantly greater for SKY than waitlist (ITT mean difference: -5.19; 95% CI, -0.93 to -9.34; P = .0097; completer mean difference: -6.23; 95% CI, -1.39 to -11.07; P = .0005). No adverse events were reported.
CONCLUSIONS: Results of this randomized, waitlist-controlled pilot study suggest the feasibility and promise of an adjunctive SKY-based intervention for patients with MDD who have not responded to antidepressants. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT02616549. © Copyright 2016 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27898207      PMCID: PMC5272872          DOI: 10.4088/JCP.16m10819

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  18 in total

Review 1.  The costs of depression.

Authors:  Ronald C Kessler
Journal:  Psychiatr Clin North Am       Date:  2011-12-16

2.  Antidepressant efficacy of Sudarshan Kriya Yoga (SKY) in melancholia: a randomized comparison with electroconvulsive therapy (ECT) and imipramine.

Authors:  N Janakiramaiah; B N Gangadhar; P J Naga Venkatesha Murthy; M G Harish; D K Subbakrishna; A Vedamurthachar
Journal:  J Affect Disord       Date:  2000 Jan-Mar       Impact factor: 4.839

Review 3.  Sudarshan Kriya yogic breathing in the treatment of stress, anxiety, and depression: part I-neurophysiologic model.

Authors:  Richard P Brown; Patricia L Gerbarg
Journal:  J Altern Complement Med       Date:  2005-02       Impact factor: 2.579

4.  Antidepressant efficacy and hormonal effects of Sudarshana Kriya Yoga (SKY) in alcohol dependent individuals.

Authors:  A Vedamurthachar; Nimmagadda Janakiramaiah; Jayaram M Hegde; Taranath K Shetty; D K Subbakrishna; S V Sureshbabu; B N Gangadhar
Journal:  J Affect Disord       Date:  2006-06-05       Impact factor: 4.839

Review 5.  Simultaneous inference in general parametric models.

Authors:  Torsten Hothorn; Frank Bretz; Peter Westfall
Journal:  Biom J       Date:  2008-06       Impact factor: 2.207

6.  Anti-anxiety efficacy of Sudarshan Kriya Yoga in general anxiety disorder: A multicomponent, yoga based, breath intervention program for patients suffering from generalized anxiety disorder with or without comorbidities.

Authors:  S Doria; A de Vuono; R Sanlorenzo; F Irtelli; C Mencacci
Journal:  J Affect Disord       Date:  2015-06-24       Impact factor: 4.839

Review 7.  Cost-of-illness studies of depression: a systematic review.

Authors:  Melanie Luppa; Sven Heinrich; Matthias C Angermeyer; Hans-Helmut König; Steffi G Riedel-Heller
Journal:  J Affect Disord       Date:  2006-09-06       Impact factor: 4.839

8.  The economic burden of treatment-resistant depression.

Authors:  Natalia Olchanski; Michelle McInnis Myers; Marilyn Halseth; Philip L Cyr; Lindsay Bockstedt; Thomas F Goss; Robert H Howland
Journal:  Clin Ther       Date:  2013-03-13       Impact factor: 3.393

9.  Mind-Body Practices and the Adolescent Brain: Clinical Neuroimaging Studies.

Authors:  Anup Sharma; Andrew B Newberg
Journal:  Adolesc Psychiatry (Hilversum)       Date:  2015

10.  A structured interview guide for the Hamilton Depression Rating Scale.

Authors:  J B Williams
Journal:  Arch Gen Psychiatry       Date:  1988-08
View more
  20 in total

1.  Applications of Yoga in Psychiatry: What We Know.

Authors:  Maren Nyer; Maya Nauphal; Regina Roberg; Chris Streeter
Journal:  Focus (Am Psychiatr Publ)       Date:  2018-01-24

2.  NAMS 2021 Utian Translational Science SymposiumSeptember 2021, Washington, DCCharting the path to health in midlife and beyond: the biology and practice of wellness.

Authors:  Nanette F Santoro; Helen L Coons; Samar R El Khoudary; C Neill Epperson; Julianne Holt-Lunstad; Hadine Joffe; Sarah H Lindsey; Kara L Marlatt; Patti Montella; Gloria Richard-Davis; Bonny Rockette-Wagner; Marcel E Salive; Cynthia Stuenkel; Rebecca C Thurston; Nancy Woods; Holly Wyatt
Journal:  Menopause       Date:  2022-05-01       Impact factor: 3.310

3.  High-Frequency Cerebral Activation and Interhemispheric Synchronization Following Sudarshan Kriya Yoga as Global Brain Rhythms: The State Effects.

Authors:  Lakshmi Bhaskar; Vaibhav Tripathi; Chhaya Kharya; Vijayalakshmi Kotabagi; Manvir Bhatia; Vinod Kochupillai
Journal:  Int J Yoga       Date:  2020-05-01

4.  Implementing Mobile HRV Biofeedback as Adjunctive Therapy During Inpatient Psychiatric Rehabilitation Facilitates Recovery of Depressive Symptoms and Enhances Autonomic Functioning Short-Term: A 1-Year Pre-Post-intervention Follow-Up Pilot Study.

Authors:  Josef M Tatschl; Sigurd M Hochfellner; Andreas R Schwerdtfeger
Journal:  Front Neurosci       Date:  2020-07-21       Impact factor: 4.677

5.  Commentary: A Breathing-Based Meditation Intervention for Patients with Major Depressive Disorder Following Inadequate Response to Antidepressants: A Randomized Pilot Study.

Authors:  Skye McKennon; Sarah Elizabeth Levitt; Grzegorz Bulaj
Journal:  Front Med (Lausanne)       Date:  2017-04-06

Review 6.  Vagus Nerve as Modulator of the Brain-Gut Axis in Psychiatric and Inflammatory Disorders.

Authors:  Sigrid Breit; Aleksandra Kupferberg; Gerhard Rogler; Gregor Hasler
Journal:  Front Psychiatry       Date:  2018-03-13       Impact factor: 4.157

7.  Yoga for posttraumatic stress disorder - a systematic review and meta-analysis.

Authors:  Holger Cramer; Dennis Anheyer; Felix J Saha; Gustav Dobos
Journal:  BMC Psychiatry       Date:  2018-03-22       Impact factor: 3.630

8.  Feasibility and Preliminary Efficacy of Tailored Yoga in Survivors of Head and Neck Cancer: A Pilot Study.

Authors:  Melissa Adair; Barbara Murphy; Sujatha Yarlagadda; Jie Deng; Mary S Dietrich; Sheila H Ridner
Journal:  Integr Cancer Ther       Date:  2018-01-22       Impact factor: 3.279

9.  5-HTTLPR and MTHFR 677C>T polymorphisms and response to yoga-based lifestyle intervention in major depressive disorder: A randomized active-controlled trial.

Authors:  Madhuri R Tolahunase; Rajesh Sagar; Rima Dada
Journal:  Indian J Psychiatry       Date:  2018 Oct-Dec       Impact factor: 1.759

10.  Isha Yoga Practices and Participation in Samyama Program are Associated with Reduced HbA1C and Systemic Inflammation, Improved Lipid Profile, and Short-Term and Sustained Improvement in Mental Health: A Prospective Observational Study of Meditators.

Authors:  Senthilkumar Sadhasivam; Suresh Alankar; Raj Maturi; Amy Williams; Ramana V Vishnubhotla; Sepideh Hariri; Mayur Mudigonda; Dhanashri Pawale; Sangeeth Dubbireddi; Senthil Packiasabapathy; Peter Castelluccio; Chithra Ram; Janelle Renschler; Tracy Chang; Balachundhar Subramaniam
Journal:  Front Psychol       Date:  2021-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.